Polyrizon
PLRZ | NASDAQ
$10.70
-$0.35 (-3.17%)
At close: Nov 16, 2026, 4:00 PM ET
$11.15
+$0.45 (+4.21%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.17%
(1D)No price chart data available for 1D timeframe.
Rating
15
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1013/1021 (Top 99%)
Key Statistics
Market Data
Market Cap $19.36M
1D Range
10.29 10.99
52W Range
3.13 17.17
Valuation (TTM)
PE -2.57
PB 0.79
EV/EBITDA -0.43
Valuation (NTM)
Forward PE N/A
Forward PEG -0.02
Price Target $0.00
Cash Flow
FCF Yield -31.1%
SBC Adj. FCF Yield -33.5%
SBC Impact -7.6%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 28.3% |
-50.8%
FCF 3Y | 5Y -106.8% |
-51.2%
Returns
ROA -22.0%
ROE -24.1%
ROIC -52.2%
Financial Health
Net Cash
$15.05M
Current Ratio 36.37
Interest Coverage -1,819.64
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier w...
Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date Oct 29, 2024
Website www.polyrizon-biotech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove PLRZ